Regence BCBS Medical Policy Updates – December 2018

Click here to view the Regence Blue Cross Blue Shield Medical Policy Updates »

December 2018 Medical Policy Updates:

• Absorbable Nasal Implant for Treatment of Nasal Valve Collapse
• Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis In Patients With Breast Cancer
• Autologous Blood-Derived Growth Factors as a Treatment for Wound Healing and Other Miscellaneous Conditions
• Bariatric Surgery
• Behavioral Table of Contents
• Cell Therapy for Peripheral Arterial Disease
• Charged-Particle (Proton) Radiotherapy
• Chromosomal Microarray Analysis (CMA) for the Genetic Evaluation of Patients with Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, or Congenital Anomalies
• Corneal Collagen Cross-Linking
• Cytochrome p450 Genotyping
• Detection of Circulating Tumor Cells in the Management of Patients with Cancer
• Durable Medical Equipment Table of Contents
• Electrical Bone Growth Stimulators (Osteogenic Stimulation)
• Extracranial Carotid Angioplasty/Stenting
• Gene-Based Tests for Screening, Detection, and/or Management of Prostate Cancer
• Genetic Testing for Epilepsy
• Genetic Testing for Hereditary Breast and/or Ovarian Cancer
• Genetic Testing for Mental Health Conditions
• Genetic Testing for Methionine Metabolism Enzymes, including MTHFR, for Indications Other than Thrombophilia
• Genetic Testing for Rett Syndrome
• Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
• Hematopoietic Cell Transplantation for Chronic Myelogenous Leukemia
• Hematopoietic Cell Transplantation for Non-Hodgkin’s Lymphomas
• Implantable Sinus Stents for Postoperative Use Following Endoscopic Sinus Surgery and for Recurrent Sinonasal Polyposis
• KIF6 Genotyping for Predicting Cardiovascular Risk and/or Effectiveness of Statin Therapy
• Laboratory Table of Contents
• Medical Policy Development and Review Process
• Multigene Expression Assay for Predicting Recurrence in Colon Cancer
• Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia
• Reconstructive Breast Surgery/Mastopexy, and Management of Breast Implants
• Reduction Mammaplasty
• Regence BlueCross BlueShield of Oregon Clinical Practice Guidelines for Physicians and other health care professionals and facilities
• Regence Vendor Contact Page
• Sublingual Immunotherapy as a Technique of Allergen Specific Therapy
• Targeted Phototherapy for Psoriasis
• The Regence Group Clinical Position Statements
• The Regence Group Medical Policy Manual
• Transgender Services
• Utilization Management Table of Contents
• Washington State Health Technology Clinical Committee (HTCC) Assessments
• Whole Exome and Whole Genome Sequencing

Click here to view the Regence Blue Cross Blue Shield Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.